Siemens Healthineers AG (OTCMKTS:SMMNY) Receives Average Recommendation of “Buy” from Brokerages

Siemens Healthineers AG (OTCMKTS:SMMNY) has received a consensus rating of “Buy” from the seven brokerages that are presently covering the firm, MarketBeat reports. Two analysts have rated the stock with a hold recommendation, two have assigned a buy recommendation and three have assigned a strong buy recommendation to the company.

Several brokerages recently commented on SMMNY. Zacks Research raised Siemens Healthineers from a “strong sell” rating to a “hold” rating in a research note on Monday, January 12th. Royal Bank Of Canada started coverage on shares of Siemens Healthineers in a research report on Wednesday, December 17th. They set a “moderate buy” rating on the stock. Sanford C. Bernstein upgraded shares of Siemens Healthineers to a “strong-buy” rating in a research note on Tuesday, January 13th. Deutsche Bank Aktiengesellschaft lowered shares of Siemens Healthineers from a “buy” rating to a “hold” rating in a research note on Thursday, December 4th. Finally, Citigroup restated a “buy” rating on shares of Siemens Healthineers in a report on Friday, January 23rd.

Siemens Healthineers Stock Performance

Shares of OTCMKTS SMMNY opened at $23.48 on Friday. Siemens Healthineers has a one year low of $23.19 and a one year high of $29.00. The business’s 50-day moving average price is $25.35 and its two-hundred day moving average price is $26.23.

Siemens Healthineers Company Profile

Siemens Healthineers AG is a leading global medical technology company that develops, manufactures and distributes a broad range of products and services for the healthcare sector. Headquartered in Erlangen, Germany, the company focuses on diagnostic and therapeutic imaging, in vitro diagnostics and advanced digital health solutions. As a spin-off from Siemens AG, Siemens Healthineers has leveraged decades of engineering expertise to establish a comprehensive portfolio that addresses critical needs in modern healthcare.

The company’s core offerings include magnetic resonance imaging (MRI), computed tomography (CT), X-ray and molecular imaging systems, as well as laboratory diagnostics equipment and point-of-care testing devices.